SPRAVATO (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Small Molecules | News Channels - PipelineReview.com

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 16:49

SPRAVATO (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Small Molecules | News Channels  PipelineReview.com